Fagotti Score at Interval Surgery in Ovarian Cancer with Flurina Saner

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Flurina Saner to discuss the Fagotti Score at interval surgery in ovarian cancer. Dr. Saner, gynecologist and obstetrician, is a gynae oncology fellow at the University Hospital Inselspital Bern, Switzerland. Her research focuses on patients with ovarian cancer and clinical and molecular determinants for long-term survival.   Highlights: The Fagotti score after neoadjuvant treatment shows a strong correlation with resection status, progression-free and overall survival of patients with advanced ovarian cancer ΔFagotti – indicating the change of the score during neoadjuvant chemotherapy - tracks with outcome after neoadjuvant chemotherapy for ovarian cancer Fagotti scores are valuable for an individualized patient treatment planning and should be routinely assessed at time of interval debulking surgery. The prognostic value of the Fagotti score after neoadjuvant therapy should be further validated in a prospective study, f.e. the LANCE trial.

Om Podcasten

The International Journal of Gynecological Cancer publishes content on novel and relevant topics in the field of gynecologic cancer. IJGC Podcast features short interview segments with leading experts discussing the latest research in their respective areas. The podcasts will serve as an interactive and education experience for all our listeners. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.